Short- and long-term outcomes after incident pneumonia in adults with chronic kidney disease: a time-dependent analysis from the Stockholm CREAtinine Measurement project.
acute kidney injury
cardiovascular disease
chronic kidney disease
mortality
pneumonia
Journal
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
ISSN: 1460-2385
Titre abrégé: Nephrol Dial Transplant
Pays: England
ID NLM: 8706402
Informations de publication
Date de publication:
01 11 2020
01 11 2020
Historique:
received:
21
01
2019
accepted:
09
05
2019
pubmed:
21
6
2019
medline:
9
3
2021
entrez:
21
6
2019
Statut:
ppublish
Résumé
Little is known about the health sequelae of pneumonia in persons with chronic kidney disease (CKD). We studied adults with CKD in Stockholm during 2006-11, who not previously been diagnosed with lower respiratory tract infections. We used multivariable-adjusted Cox regression with pneumonia as a time-varying exposure to estimate hazard ratios (HRs) [95% confidence intervals (CIs)] for the events of death, major adverse cardiovascular events (MACEs), acute kidney injury (AKI), CKD progression or hospitalization for urinary tract infections (UTIs)/sepsis. Cataract and knee/joint replacement served as negative control outcomes. We identified 71 931 adults (mean age 79 years, 59% women), of whom 8379 (12%) were diagnosed with pneumonia during follow-up; incident pneumonia was associated with 10 times higher adjusted mortality risk during the first 90 days [HR = 10.0, 95% confidence interval (CI) 9.5-10.5] and double the mortality beyond 90 days from pneumonia diagnosis (HR = 2.0; 95% CI 1.9-2.1). Incident pneumonia was similarly associated with higher adjusted risk of MACE (<90 days: HR = 12.6; 95% CI 12.0-13.3; ≥90 days: HR = 1.5; 95% CI 1.4-1.6). The adjusted risk of CKD progression and UTI/sepsis hospitalization was highest within 90 days from pneumonia but remained elevated thereafter. For AKI, the association with incident pneumonia was only seen within 90 days. Neither cataract nor knee/joint replacement was related to pneumonia. Incident pneumonia was associated with increased risks of MACE, CKD progression, severe UTI/sepsis and death, with risks highest soon after pneumonia diagnosis but extending beyond 90 days. Our findings highlight the susceptibility for adverse outcomes of CKD patients following pneumonia diagnosis, and may inform clinical decisions regarding vaccination strategies.
Sections du résumé
BACKGROUND
Little is known about the health sequelae of pneumonia in persons with chronic kidney disease (CKD).
METHODS
We studied adults with CKD in Stockholm during 2006-11, who not previously been diagnosed with lower respiratory tract infections. We used multivariable-adjusted Cox regression with pneumonia as a time-varying exposure to estimate hazard ratios (HRs) [95% confidence intervals (CIs)] for the events of death, major adverse cardiovascular events (MACEs), acute kidney injury (AKI), CKD progression or hospitalization for urinary tract infections (UTIs)/sepsis. Cataract and knee/joint replacement served as negative control outcomes.
RESULTS
We identified 71 931 adults (mean age 79 years, 59% women), of whom 8379 (12%) were diagnosed with pneumonia during follow-up; incident pneumonia was associated with 10 times higher adjusted mortality risk during the first 90 days [HR = 10.0, 95% confidence interval (CI) 9.5-10.5] and double the mortality beyond 90 days from pneumonia diagnosis (HR = 2.0; 95% CI 1.9-2.1). Incident pneumonia was similarly associated with higher adjusted risk of MACE (<90 days: HR = 12.6; 95% CI 12.0-13.3; ≥90 days: HR = 1.5; 95% CI 1.4-1.6). The adjusted risk of CKD progression and UTI/sepsis hospitalization was highest within 90 days from pneumonia but remained elevated thereafter. For AKI, the association with incident pneumonia was only seen within 90 days. Neither cataract nor knee/joint replacement was related to pneumonia.
CONCLUSIONS
Incident pneumonia was associated with increased risks of MACE, CKD progression, severe UTI/sepsis and death, with risks highest soon after pneumonia diagnosis but extending beyond 90 days. Our findings highlight the susceptibility for adverse outcomes of CKD patients following pneumonia diagnosis, and may inform clinical decisions regarding vaccination strategies.
Identifiants
pubmed: 31219575
pii: 5521079
doi: 10.1093/ndt/gfz119
pmc: PMC7643674
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1894-1900Informations de copyright
© The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA.
Références
J Am Soc Nephrol. 2016 Jun;27(6):1727-40
pubmed: 26453613
Medicine (Baltimore). 2014 Dec;93(27):e174
pubmed: 25501062
J Am Soc Nephrol. 2015 Oct;26(10):2504-11
pubmed: 25733525
JAMA. 2014 Jun 4;311(21):2199-208
pubmed: 24893087
Chest. 2010 Oct;138(4):825-32
pubmed: 20435657
Nephrol Dial Transplant. 2011 Sep;26(9):2934-9
pubmed: 21317410
Thromb Res. 2016 Aug;144:123-6
pubmed: 27322088
Lancet. 2016 Jan 16;387(10015):251-72
pubmed: 26510778
Kidney Int. 2010 Mar;77(6):527-35
pubmed: 20032961
BMC Public Health. 2011 Jun 09;11:450
pubmed: 21658213
Eur Heart J. 2014 Mar;35(9):578-89
pubmed: 24026779
Am J Kidney Dis. 2012 Dec;60(6):959-65
pubmed: 22694948
Kidney Int. 2016 Oct;90(4):897-904
pubmed: 27591084
N Engl J Med. 2015 Jul 30;373(5):415-27
pubmed: 26172429
J Infect. 2016 Aug;73(2):107-14
pubmed: 27288596
PLoS One. 2011;6(8):e22847
pubmed: 21853050
Kidney Int. 2011 Dec;80(11):1231-8
pubmed: 21866089
JAMA. 1998 May 13;279(18):1452-7
pubmed: 9600479
Eur Respir J. 2013 Sep;42(3):559-63
pubmed: 24000245
JAMA. 2015 Jan 20;313(3):264-74
pubmed: 25602997
Kidney Int. 2014 Nov;86(5):905-14
pubmed: 24621918
Thorax. 2012 Jan;67(1):71-9
pubmed: 20729232
Am J Respir Crit Care Med. 2008 Jun 1;177(11):1242-7
pubmed: 18369199
Lancet Infect Dis. 2010 Feb;10(2):83-92
pubmed: 20113977
Am J Kidney Dis. 2017 Jun;69(6):752-761
pubmed: 27884474
J Am Coll Cardiol. 2014 Nov 4;64(18):1917-25
pubmed: 25444147
Am J Kidney Dis. 2004 Jun;43(6):976-82
pubmed: 15168377
Clin Kidney J. 2016 Feb;9(1):119-27
pubmed: 26798472
PLoS One. 2016 Nov 17;11(11):e0166092
pubmed: 27855182
Kidney Int. 2014 Nov;86(5):1023-30
pubmed: 24694991
Am J Kidney Dis. 2009 Jul;54(1):24-32
pubmed: 19447535
Kidney Int. 2012 Mar;81(5):442-8
pubmed: 22113526
Clin J Am Soc Nephrol. 2017 Sep 7;12(9):1399-1408
pubmed: 28818849
Eur J Intern Med. 2018 Sep;55:23-27
pubmed: 29754939
Clin Epidemiol. 2018 Aug 14;10:971-979
pubmed: 30147376
J Am Coll Cardiol. 2015 Nov 17;66(20):2173-2184
pubmed: 26564594
Am J Kidney Dis. 2018 Mar;71(3 Suppl 1):A7
pubmed: 29477157
Circulation. 2003 Feb 11;107(5):762-8
pubmed: 12578882
Lancet. 2013 Feb 9;381(9865):496-505
pubmed: 23332146
BMJ Open. 2014 Apr 17;4(4):e004100
pubmed: 24742975
Am J Respir Crit Care Med. 2015 Apr 1;191(7):739-45
pubmed: 25629643
Am J Kidney Dis. 2009 Apr;53(4):596-605
pubmed: 19110358
PLoS One. 2016 Jun 30;11(6):e0158501
pubmed: 27362355
Lancet. 2015 Sep 12;386(9998):1097-108
pubmed: 26277247
Arch Intern Med. 2007 Aug 13-27;167(15):1655-63
pubmed: 17698689
Ann Epidemiol. 2013 May;23(5):291-3
pubmed: 23522903
PLoS Med. 2011 Jun;8(6):e1001048
pubmed: 21738449
Am J Kidney Dis. 2012 Aug;60(2):225-32
pubmed: 22560844
Nephrol Dial Transplant. 2011 Sep;26(9):2899-906
pubmed: 21273232